The Performance Evaluation of Pharmaceutical Enterprises’ R&D Team Based on ANP

Mo Zhang (daisymo0226@gmail.com), Xiaoli Wang (xiaoli-wang@tongji.edu.cn), Tiezheng Mao (orca.mao@foxmail.com) and Cheng Cheng (1423806765@qq.com)
Additional contact information
Mo Zhang: School of Economics and Business Administration Tongji University
Xiaoli Wang: School of Economics and Business Administration Tongji University
Tiezheng Mao: ORCA Digital Studio
Cheng Cheng: Northeast forestry university

A chapter in LISS 2014, 2015, pp 837-841 from Springer

Abstract: Abstract Taken in full consideration of pharmaceutical enterprises characteristics, a set of R&D team performance evaluation index system composed by technical innovation, team cooperation ability, team achievement was established. The index system consists of 3 primary indexes, 9 secondary indexes and 22 tertiary indexes. The result shows that technical innovation playing an important role in R&D team, and the system implementation is ranked first, which prove the project funding, technology assessment pass rate of R&D team to be critical.

Keywords: R&D team; Performance evaluation; ANP (search for similar items in EconPapers)
Date: 2015
References: Add references at CitEc
Citations:

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:sprchp:978-3-662-43871-8_120

Ordering information: This item can be ordered from
http://www.springer.com/9783662438718

DOI: 10.1007/978-3-662-43871-8_120

Access Statistics for this chapter

More chapters in Springer Books from Springer
Bibliographic data for series maintained by Sonal Shukla (sonal.shukla@springer.com) and Springer Nature Abstracting and Indexing (indexing@springernature.com).